• S02E04 Beyond the surface Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

  • Aug 15 2022
  • Length: 10 mins
  • Podcast

S02E04 Beyond the surface Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

Listen for free

View show details

  • Summary

  • Beyond the surface. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

    A modern landmark glaucoma trial and first-of-its-kind that provides surprising and useful outcomes for current practice and research. Can the visual field be preserved with an intraocular-pressure-lowering drug in patients with open-angle glaucoma? Dr Jennifer Fan Gaskin explores Latanoprost for open-angle glaucoma.

    View article here

    Jennifer Fan Gaskin is a Consultant Ophthalmologist at the Royal Victorian Eye and Ear Hospital and a Principal Investigator at the Centre for Eye Research Australia where she leads Ocular Fibrosis Research. In 2021 she was named a Superstar of STEM by Science and Technology Australia. She is a Director of Australian Vision Research (formerly known as the Ophthalmic Research Institute of Australia) and a board member of the Australian and New Zealand Glaucoma Society.
    Show More Show Less
Show More Show Less
activate_samplebutton_t1

What listeners say about S02E04 Beyond the surface Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available